Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22Colonic Neoplasms 12Rectal Neoplasms 11Carcinoma, Hepatocellular 10Stomach Neoplasms 7Digestive System Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Neoplasm Metastasis 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cholangiocarcinoma 2Recurrence 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoadjuvant Therapy 1Liver Neoplasms 1Intestinal Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Advanced Colorectal Cancer 1

Interventions

pembrolizumab 4anlotinib 4sintilimab 3Paclitaxel 3Leucovorin 3Cetuximab 3niraparib 2Sorafenib 2Radiotherapy 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Docetaxel 2Cisplatin 2vistusertib 1titanium silicide 1tislelizumab 1tirbanibulin 1surufatinib 1regorafenib 1pemigatinib 1olaparib 1elemene 1durvalumab 1donafenib 1daromun 1avelumab 1aumolertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma × Folfox protocol × Clear all
NCT04962958 2023-06-22

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
30 enrolled
Gastrointestinal

Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡